Evaluation of a Neurokinin-1 Receptor-Targeted Technetium-99m Conjugate for Neuroendocrine Cancer Imaging.
Ananda Kumar KanduluruMadduri SrinivasaraoCharity WayuaPhilip S LowPublished in: Molecular imaging and biology (2021)
The excellent tumor contrast afforded by our NK1R-targeted radioimaging agent exhibits properties that could improve early diagnosis and staging of many neuroendocrine tumors.